Dr. Abhay Sanan is a Neurosurgeon with more than 24 years of experience in broad areas of neurosciences. He understands how technology drives outcomes and is currently leading a clinical partnership with INanoBio for development of diagnostic technologies for early CNS disease detection, with an initial focus on brain tumors. He is a board certified neurosurgeon who has held numerous management positions. In addition to his role at Center for Neurosciences Tucson, he serves as Director of Neurosciences at Tucson Medical Center and as Clinical Assistant Professor at the University of Arizona, Division of Neurosurgery. Dr. Sanan and his research have received numerous awards throughout his career.
GENOME SEQUENCING
Sequencing a person’s genome can identify susceptibility to various diseases, aid in early disease diagnosis, and enable precision medicine – personalization of therapy based on individual specific genomic biomarkers.
CANCER DIAGNOSTICS
Detecting diseases in early stages dramatically improves therapeutic outcomes. In Cancer, average 5 year survival rate is close to 90% when diagnosed at stage 1, and stands at less than 25% when diagnosed at stage 4. In contrast, cost of therapy when diagnosed post metastasis is approximately 2.5 times that when diagnosed at early stages.
